Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Galbraith

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Iscience|August 13, 2025
Interferon signaling modulates Down syndrome-associated Alzheimer's disease pathology in a mouse modelPaula Araya, Brian Niemeyer, Kyndal Schade, et al.
Science Advances|June 28, 2023
Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibitionMatthew D Galbraith, Angela L Rachubinski, Keith P Smith, et al.
Cell Reports. Medicine|December 20, 2025
Blood measure of neuronal death is exponentially higher with age, especially in females, and halted in Alzheimer's disease by GM-CSF treatmentStefan H Sillau, Christina Coughlan, Md Mahiuddin Ahmed, et al.
Molecular Cell|September 10, 2019
Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 FunctionsIris Steinparzer, Vitaly Sedlyarov, Jonathan D Rubin, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Attenuated estrogen signaling disrupts placentation and drives trophoblast defects in Down syndromeDeirdre M Logsdon, Isabela T Pereira, Kindyll L Wetta, et al.
Cell Reports|August 9, 2024
Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndromeMicah G Donovan, Angela L Rachubinski, Keith P Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2020
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Elife|March 16, 2021
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
The Journal of Allergy and Clinical Immunology|August 29, 2024
Metabolic dysfunction mediated by HIF-1α contributes to epithelial differentiation defects in eosinophilic esophagitisSinéad Ryan, Louise Crowe, Sofía N Almeida Cruz, et al.
Nature Metabolism|November 13, 2023
Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cellsSamantha J Linder, Tiziano Bernasocchi, Bárbara Martínez-Pastor, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Iscience|August 13, 2025
Interferon signaling modulates Down syndrome-associated Alzheimer's disease pathology in a mouse modelPaula Araya, Brian Niemeyer, Kyndal Schade, et al.
Science Advances|June 28, 2023
Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibitionMatthew D Galbraith, Angela L Rachubinski, Keith P Smith, et al.
Cell Reports. Medicine|December 20, 2025
Blood measure of neuronal death is exponentially higher with age, especially in females, and halted in Alzheimer's disease by GM-CSF treatmentStefan H Sillau, Christina Coughlan, Md Mahiuddin Ahmed, et al.
Molecular Cell|September 10, 2019
Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 FunctionsIris Steinparzer, Vitaly Sedlyarov, Jonathan D Rubin, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Attenuated estrogen signaling disrupts placentation and drives trophoblast defects in Down syndromeDeirdre M Logsdon, Isabela T Pereira, Kindyll L Wetta, et al.
Cell Reports|August 9, 2024
Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndromeMicah G Donovan, Angela L Rachubinski, Keith P Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2020
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Elife|March 16, 2021
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
The Journal of Allergy and Clinical Immunology|August 29, 2024
Metabolic dysfunction mediated by HIF-1α contributes to epithelial differentiation defects in eosinophilic esophagitisSinéad Ryan, Louise Crowe, Sofía N Almeida Cruz, et al.
Nature Metabolism|November 13, 2023
Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cellsSamantha J Linder, Tiziano Bernasocchi, Bárbara Martínez-Pastor, et al.
Pageof 15